Encore Medical Asset Corporation

United States of America

Back to Profile

1-9 of 9 for Encore Medical Asset Corporation Sort by
Query
Aggregations
Date
2020 1
Before 2020 8
IPC Class
A61N 1/30 - Apparatus for iontophoresis or cataphoresis 7
A61N 1/04 - Electrodes 4
A61N 1/32 - Applying electric currents by contact electrodes alternating or intermittent currents 3
A61N 1/00 - ElectrotherapyCircuits therefor 2
A61K 9/22 - Sustained or differential release type 1
Found results for  patents

1.

Method and apparatus for electrotherapy drug delivery

      
Application Number 16687343
Grant Number 11541226
Status In Force
Filing Date 2019-11-18
First Publication Date 2020-05-07
Grant Date 2023-01-03
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Beck, Jon E.
  • Hause, Jr., Robert F.

Abstract

The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.

IPC Classes  ?

  • A61N 1/04 - Electrodes
  • A61N 1/30 - Apparatus for iontophoresis or cataphoresis
  • A61N 1/32 - Applying electric currents by contact electrodes alternating or intermittent currents

2.

Method for electrotherapy drug delivery

      
Application Number 15295828
Grant Number 10478610
Status In Force
Filing Date 2016-10-17
First Publication Date 2017-05-11
Grant Date 2019-11-19
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Beck, Jon E.
  • Hause, Jr., Robert F.

Abstract

The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.

IPC Classes  ?

  • A61N 1/30 - Apparatus for iontophoresis or cataphoresis
  • A61N 1/04 - Electrodes
  • A61N 1/32 - Applying electric currents by contact electrodes alternating or intermittent currents

3.

Iontophoretic electrode

      
Application Number 14935249
Grant Number 09757553
Status In Force
Filing Date 2015-11-06
First Publication Date 2016-03-03
Grant Date 2017-09-12
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Koschinsky, Ralph
  • Isaacson, James D.
  • Hause, Robert F.

Abstract

An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.

IPC Classes  ?

4.

Method and apparatus for electrotherapy drug delivery

      
Application Number 14295120
Grant Number 09468757
Status In Force
Filing Date 2014-06-03
First Publication Date 2014-09-25
Grant Date 2016-10-18
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Beck, Jon E.
  • Hause, Jr., Robert F.

Abstract

The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.

IPC Classes  ?

  • A61N 1/32 - Applying electric currents by contact electrodes alternating or intermittent currents
  • A61N 1/04 - Electrodes
  • A61N 1/30 - Apparatus for iontophoresis or cataphoresis

5.

Iontophoretic electrode

      
Application Number 10587429
Grant Number 08024033
Status In Force
Filing Date 2005-02-28
First Publication Date 2008-03-06
Grant Date 2011-09-20
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Koschinsky, Ralph
  • Isaacson, James D.
  • Hause, Jr., Robert F.

Abstract

An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.

IPC Classes  ?

  • A61N 1/30 - Apparatus for iontophoresis or cataphoresis

6.

Iontophoresis apparatus and method

      
Application Number 11733692
Grant Number 07996077
Status In Force
Filing Date 2007-04-10
First Publication Date 2008-03-06
Grant Date 2011-08-09
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Hause, Jr., Robert F.
  • Beck, Jon E.

Abstract

An iontophoresis apparatus and method is disclosed that is suited to deliver a plurality of treatment methods such as, but not limited to, body site conductivity enhancement followed by low voltage iontophoresis.

IPC Classes  ?

  • A61N 1/30 - Apparatus for iontophoresis or cataphoresis
  • A61N 1/00 - ElectrotherapyCircuits therefor

7.

Iontophoresis apparatus and method

      
Application Number 11733700
Grant Number 08214030
Status In Force
Filing Date 2007-04-10
First Publication Date 2008-03-06
Grant Date 2012-07-03
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Hause, Jr., Robert F.
  • Beck, Jon E.

Abstract

An iontophoresis apparatus and method is disclosed that is suited to deliver a plurality of treatment methods such as, but not limited to, body site conductivity enhancement followed by low voltage iontophoresis.

IPC Classes  ?

  • A61N 1/30 - Apparatus for iontophoresis or cataphoresis

8.

Apparatus for electrotherapy drug delivery with added impurities

      
Application Number 10907429
Grant Number 08386029
Status In Force
Filing Date 2005-03-31
First Publication Date 2006-10-12
Grant Date 2013-02-26
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Hause, Jr., Robert F.
  • Beck, Jon E.

Abstract

The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.

IPC Classes  ?

  • A61N 1/30 - Apparatus for iontophoresis or cataphoresis
  • A61K 9/22 - Sustained or differential release type

9.

Independent protection system for an electrical muscle stimulation apparatus and method of using same

      
Application Number 11343245
Grant Number 08140165
Status In Force
Filing Date 2006-01-30
First Publication Date 2006-09-28
Grant Date 2012-03-20
Owner Encore Medical Asset Corporation (USA)
Inventor
  • Bühlmann, Félix
  • Dunant, Etienne
  • Guex, Steve
  • Truffer, David
  • Müller, Pierre-Yves

Abstract

Electrotherapy systems and methods for delivering an electrostimulation treatment program to a user while reducing the risk of inducing cardiac fibrillation. The systems and methods detect electrostimulation treatment program delivery characteristics, including a pulse intensity above a preset limit; a pulse duration above a preset limit; an inappropriately compensated pulse; a charge per pulse above a predetermined limit; a current improperly exiting from a stimulation channel; a current present outside of a pulse; an excitation pulse and a compensation pulse generated on different channels; an inter-pulse time less than a predetermined limit; and a time between an excitation and a compensation pulse greater than a predetermined limit. The limits are selected in relation to an objective of reducing the risk of inducing cardiac fibrillation.

IPC Classes  ?

  • A61N 1/00 - ElectrotherapyCircuits therefor